Application of the “risk of ambulatory disability” (RoAD) score in a “real‐world” single‐center multiple sclerosis cohort

Survival analysis of reaching EDSS ≥4.0 based on RoAD score ≥4 (dashed line) and <4 (solid line) by Cox regression analysis. (A) Unadjusted regression analysis. (B) Regression controlled for sex and immunotherapy groups, and the trajectory of treatment changes during follow‐up.[Image: see text]...

Descripción completa

Detalles Bibliográficos
Autores principales: Pistor, Maximilian, Hammer, Helly, Salmen, Anke, Hoepner, Robert, Friedli, Christoph
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Letters to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8981428/
https://www.ncbi.nlm.nih.gov/pubmed/35060326
http://dx.doi.org/10.1111/cns.13806
_version_ 1784681601749221376
author Pistor, Maximilian
Hammer, Helly
Salmen, Anke
Hoepner, Robert
Friedli, Christoph
author_facet Pistor, Maximilian
Hammer, Helly
Salmen, Anke
Hoepner, Robert
Friedli, Christoph
author_sort Pistor, Maximilian
collection PubMed
description Survival analysis of reaching EDSS ≥4.0 based on RoAD score ≥4 (dashed line) and <4 (solid line) by Cox regression analysis. (A) Unadjusted regression analysis. (B) Regression controlled for sex and immunotherapy groups, and the trajectory of treatment changes during follow‐up.[Image: see text]
format Online
Article
Text
id pubmed-8981428
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-89814282022-04-11 Application of the “risk of ambulatory disability” (RoAD) score in a “real‐world” single‐center multiple sclerosis cohort Pistor, Maximilian Hammer, Helly Salmen, Anke Hoepner, Robert Friedli, Christoph CNS Neurosci Ther Letters to the Editor Survival analysis of reaching EDSS ≥4.0 based on RoAD score ≥4 (dashed line) and <4 (solid line) by Cox regression analysis. (A) Unadjusted regression analysis. (B) Regression controlled for sex and immunotherapy groups, and the trajectory of treatment changes during follow‐up.[Image: see text] John Wiley and Sons Inc. 2022-01-21 /pmc/articles/PMC8981428/ /pubmed/35060326 http://dx.doi.org/10.1111/cns.13806 Text en © 2022 The Authors. CNS Neuroscience & Therapeutics Published by John Wiley & Sons Ltd. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Letters to the Editor
Pistor, Maximilian
Hammer, Helly
Salmen, Anke
Hoepner, Robert
Friedli, Christoph
Application of the “risk of ambulatory disability” (RoAD) score in a “real‐world” single‐center multiple sclerosis cohort
title Application of the “risk of ambulatory disability” (RoAD) score in a “real‐world” single‐center multiple sclerosis cohort
title_full Application of the “risk of ambulatory disability” (RoAD) score in a “real‐world” single‐center multiple sclerosis cohort
title_fullStr Application of the “risk of ambulatory disability” (RoAD) score in a “real‐world” single‐center multiple sclerosis cohort
title_full_unstemmed Application of the “risk of ambulatory disability” (RoAD) score in a “real‐world” single‐center multiple sclerosis cohort
title_short Application of the “risk of ambulatory disability” (RoAD) score in a “real‐world” single‐center multiple sclerosis cohort
title_sort application of the “risk of ambulatory disability” (road) score in a “real‐world” single‐center multiple sclerosis cohort
topic Letters to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8981428/
https://www.ncbi.nlm.nih.gov/pubmed/35060326
http://dx.doi.org/10.1111/cns.13806
work_keys_str_mv AT pistormaximilian applicationoftheriskofambulatorydisabilityroadscoreinarealworldsinglecentermultiplesclerosiscohort
AT hammerhelly applicationoftheriskofambulatorydisabilityroadscoreinarealworldsinglecentermultiplesclerosiscohort
AT salmenanke applicationoftheriskofambulatorydisabilityroadscoreinarealworldsinglecentermultiplesclerosiscohort
AT hoepnerrobert applicationoftheriskofambulatorydisabilityroadscoreinarealworldsinglecentermultiplesclerosiscohort
AT friedlichristoph applicationoftheriskofambulatorydisabilityroadscoreinarealworldsinglecentermultiplesclerosiscohort

Ejemplares similares